Business · 16/10/20261 min read

U.S. Anesthesia Partners Celebrates World Anesthesia Day 2026

Summary

U.S. Anesthesia Partners honors nearly 180 years of progress in anesthesiology, from the first public demonstration of ether to today's precision-guided anesthesia care.

Original source language: PR NewswireOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Business · 10/23/2026

NEW YORK CITY Unveils the International Room - NYC's first and only exclusive high-roller gaming destination

The exclusive new space brings private gaming salons, personalized luxury hospitality and around the clock dining to Queens as Resorts World NYC celebrates its 15th anniversary NEW YORK, Oct. 22, 2026 — ...

Read summary →

Business · 10/23/2026

Harbour BioMed receives China NMPA approval for Batoclimab injection (subcutaneous injection) for the treatment of generalized myasthenia gravis

The first NMPA-approved anti-FcRn therapy to complete its full clinical development for gMG patients in China CAMBRIDGE, Mass. , ROTTERDAM, Netherlands and SHANGHAI, Oct. 22, 2026 — Harbour BioMed (the "C...

Read summary →

Business · 10/23/2026

Superior Products of Qingdao Shine at SIAL Paris with 82 Million Yuan in Intended Orders

PARIS, Oct. 22, 2026 — A report from iQingdao: From October 17 to 21, 2026, SIAL Paris was held. Seizing opportunities in the global food market, the Qingdao Council for the Promotion of International Tr...

Read summary →

Business · 10/23/2026

Paradigm Therapeutics, Inc. announces that the first patient to be admitted to the Phase 3 study on SD-101 (ZorblesiaTM) for epidermolysis bullosa was a new patient in the family of EDF-D2 and EDF.

SD-101 (ZorblesiaTM) is the first topical therapy to be developed for the treatment of wounds and lesions on the entire skin surface in patients with the three main subtypes of epidermolysis bullosa...

Read summary →

Business · 10/23/2026

TTM Technologies Investigation Notice: SueWallSt notifies investors of pending investigation into TTM technologies (TTMI)

TTM Technologies stock saw a quarter of its share price disappear following the publication of its third-quarter results.An investigation into potential securities law violations is underway. NEW YORK, Oct. 22, 2026...

Read summary →

Business · 10/23/2026

Media announcement: Infrastructure announcements in Essex County

ESSEX, ON, 22 October 2026 /CNW/ -- Media representatives are invited to an infrastructure announcement in the presence of Jennifer Mckelvie, Parliamentary Secretary to the Minister for Housing and Infrastructure...

Read summary →